天保基建：10月23日召开董事会会议

Group 1 - The core point of the article is that Tianbao Infrastructure (SZ 000965) held its 28th meeting of the 9th Board of Directors on October 23, 2025, where it reviewed the proposal for the reappointment of the annual audit institution [1] - For the first half of 2025, the revenue composition of Tianbao Infrastructure is as follows: 85.93% from real estate development and operation, 6.21% from property leasing, 6.2% from property management, 1.47% from hotel income, and 0.2% from pharmaceutical sales [1] - As of the report date, the market capitalization of Tianbao Infrastructure is 5.1 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing this year, indicating a hot secondary market in biomedicine, while the primary market is facing fundraising challenges [1]